Analysis on risk factors of pulmonary infection after renal transplantation from organ donation after citizen's death
-
摘要:
目的 探讨公民逝世后器官捐献供肾肾移植术后受者发生肺部感染的影响因素。 方法 回顾性分析中南大学湘雅三医院器官移植中心自2010年4月至2014年12月公民逝世后器官捐献供肾肾移植125例供者与210例受者的临床资料。根据移植术后有否发生肺部感染将受者分为肺部感染组(37例)和无肺部感染组(173例)。了解肺部感染受者的一般情况和预后。对供者因素(性别、年龄、维持治疗时间、感染史)、受者因素[性别、年龄、吸烟史、糖尿病史,术前血红蛋白、白细胞、中性粒细胞百分比、白蛋白、血清肌酐等水平,术后有否急性排斥反应、有否使用生物制剂、有否预防性应用更昔洛韦及复方磺胺甲噁唑(SMZ)]进行单因素分析和多因素Logistic回归分析,找出肺部感染的独立危险因素。 结果与结论 37例肺部感染患者中,8例发展为重症肺部感染死亡。公民逝世后器官捐献供肾肾移植术后受者发生肺部感染的独立危险因素包括供体维持治疗时间、有感染史,受体吸烟史、糖尿病史、无预防性应用更昔洛韦或SMZ。 Abstract:Objective To investigate the risk factors of pulmonary infection after renal transplantation from organ donation after citizen's death. Methods Clinical data of 125 donors and 210 recipients admitted to Organ Transplantation Center, the Third Xiangya Hospital of Central South Hospital from April 2010 to December 2014 were retrospectively analyzed. All recipients were divided into the pulmonary infection (n=37) and non-pulmonary infection groups (n=173) according to the incidence of pulmonary infection after renal transplantation. General data and clinical prognosis of the recipients with pulmonary infection were evaluated. Risk factors of the donors (gender, age, maintenance therapy time, infection history) and those of the recipients [gender, age, smoking history, diabetes mellitus history, preoperative levels of hemoglobin, leukocyte, percentage of neutrophilic leukocyte, albumin and serum creatinine, postoperative presence of acute rejection, use of biological agents and preventive application of ganciclovir and compound sulfamethoxazole (SMZ)] were subject to single factor analysis and multi-variate Logistic regression analysis to identify the independent risk factors of pulmonary infection. Results and conclusions Among 37 patients with pulmonary infection, 8 died due to progression to severe pulmonary infection. The independent risk factors of pulmonary infection following renal transplantation from organ donation after citizen's death include maintenance therapy time and infection history for the donors, smoking history, diabetes mellitus history and preventive use of ganciclovir or SMZ for the recipients. -
表 1 肾移植术后肺部感染的单因素分析结果
Table 1. Single factor analysis results of pulmonary infection after renal transplantation
影响因素 肺部感染组 非肺部感染组 P值 供体 性别(男/女) 17/14 48/46 0.074 年龄(岁) 41±8 43±10 0.753 维持治疗时间(d) 15±5 9±4 < 0.001 感染史(有/否) 22/9 20/74 < 0.001 受体 性别(男/女) 20/17 114/59 0.064 年龄(岁) 35±10 35±10 0.069 吸烟史(有/否) 25/12 22/151 < 0.0001 糖尿病史(有/否) 7/30 3/170 < 0.0001 术前血红蛋白(g/L) 88±11 89±11 0.276 术前白细胞(×109/L) 7.0±0.3 6.0±0.4 0.067 术前中性粒细胞百分比 0.74±0.09 0.70±0.08 0.081 术前白蛋白(g/L) 30±5 30±5 0.579 术前血清肌酐(μmol/L) 1 024±512 964±486 0.283 术后急性排斥反应(有/否) 21/16 24/149 < 0.001 术后使用生物制剂(有/否) 20/17 17/156 < 0.001 术后预防性应用更昔洛韦(有/否) 12/25 150/23 < 0.001 术后预防性应用SMZ(有/否) 19/18 127/46 0.034 表 2 肾移植术后肺部感染的多因素分析结果
Table 2. Multiple factors analysis results of pulmonary infection after renal transplantation
相关因素 回归系数 比值比 95%可信区间 P值 供体维持治疗时间 2.128 10.047 3.127~54.124 0.001 供体感染史 2.432 10.493 2.342~46.417 0.042 受体吸烟史 1.846 7.543 1.467~35.714 0.009 受体糖尿病史 2.169 9.137 1.971~35.312 0.035 受体无预防性应用更昔洛韦 2.013 5.218 1.147~33.785 < 0.001 受体无预防性应用SMZ 2.248 14.231 3.498~55.993 0.032 -
[1] 李文浩, 苏泽轩, 叶泽兵, 等.肾移植术后肺部感染预后的Cox风险模型分析[J].器官移植, 2015, 6(3):179-183. http://www.organtranspl.com/browse/detail/qkid/72/id/82.htmlLi WH, Su ZX, Ye ZB, et al. Analysis on prognosis of pulmonary infection after renal transplantation by Cox risk model[J]. Organ Transplant, 2015, 6(3):179-183. http://www.organtranspl.com/browse/detail/qkid/72/id/82.html [2] 张铖, 钱叶勇, 石炳毅, 等.实体器官移植术后结核病的研究进展——2013年美国移植协会感染病学组实体器官移植结核病诊疗指南剖析[J].器官移植, 2015, 6(1):64-67. http://www.organtranspl.com/browse/detail/qkid/70/id/118.htmlZhang C, Qian YY, Shi BY, et al. Research progress on tuberculosis after solid organ transplantation: analysis of diagnosis and treatment on tuberculosis after solid organ transplantation from AST Infectious Diseases Community of Practice in 2013[J]. Organ Transplant, 2015, 6(1):64-67. http://www.organtranspl.com/browse/detail/qkid/70/id/118.html [3] 廖贵益, 赵奇, 唐亮, 等.肾移植后肺部感染14例治疗体会[J].实用医学杂志, 2014, 30(17):2798-2800. http://www.cnki.com.cn/Article/CJFDTOTAL-SYYZ201417037.htmLiao GY, Zhao Q, Tang L, et al. Treatment experience on pulmonary infection after renal transplantation in 14 cases[J]. J Pract Med, 2014, 30(17):2798-2800. http://www.cnki.com.cn/Article/CJFDTOTAL-SYYZ201417037.htm [4] Fehr T, Cippà PE, Mueller NJ. Cytomegalovirus post kidney transplantation: prophylaxis versus pre-emptive therapy?[J]. Transpl Int, 2015, 28(12):1351-1356. doi: 10.1111/tri.12629 [5] 中华人民共和国卫生部.医院感染诊断标准(试行)[J].中华医学杂志, 2001, 81(5):314-320. http://www.cnki.com.cn/Article/CJFDTOTAL-ZHYX200105025.htmMinistry of Health of the People's Republic of China. Diagnostic criteria for nosocomial infections(proposed)[J]. Natl Med J China, 2001, 81(5):314-320. http://www.cnki.com.cn/Article/CJFDTOTAL-ZHYX200105025.htm [6] Mori T.Post-transplant infectious diseases[J]. Rinsho Ketsueki, 2014, 55(10):2136-2141. http://europepmc.org/abstract/MED/26367361 [7] Tu GW, Ju MJ, Zheng YJ, et al. An interdisciplinary approach for renal transplant recipients with severe pneumonia: a single ICU experience[J]. Intensive Care Med, 2014, 40(6):914-915. doi: 10.1007/s00134-014-3296-6 [8] Tu GW, Ju MJ, Han Y, et al. Moderate-dose glucocorticoids as salvage therapy for severe pneumonia in renal transplant recipients: a single-center feasibility study[J]. Ren Fail, 2014, 36(2):202-209. doi: 10.3109/0886022X.2013.846771 [9] 郭鹏, 王瑜, 解志远, 等.肾移植术后围手术期肺部感染分析[J].广东医学, 2010, 31(10): 1290-1292. http://www.cnki.com.cn/Article/CJFDTOTAL-GAYX201010038.htmGuo P, Wang Y, Xie ZY, et al. Analysis of perioperative pulmonary infection after renal transplantation[J]. Guangdong Med J, 2010, 31(10):1290-1292. http://www.cnki.com.cn/Article/CJFDTOTAL-GAYX201010038.htm [10] Canterino JE, McCormack M, Gurung A, et al. Cytomegalovirus appendicitis in an immunocompetent host[J]. J Clin Virol, 2016, 78:9-11. doi: 10.1016/j.jcv.2016.02.011 [11] 张燕燕, 张晓东, 李瑛, 等.肾移植术后患者肺部感染及预后因素分析[J].河北医药, 2013, 35(7):1013-1015. http://www.cnki.com.cn/Article/CJFDTOTAL-HBYZ201307028.htmZhang YY, Zhang XD, Li Y, et al. The analysis of pulmonary infection and prognostic factors of patients after renal transplantation[J]. Hebei Med J, 2013, 35(7):1013-1015. http://www.cnki.com.cn/Article/CJFDTOTAL-HBYZ201307028.htm [12] Nyumura I, Honda K, Babazono T, et al. Recurrence of diabetic kidney disease in a type 1 diabetic patient after kidney transplantation[J]. Nephrology, 2015, 20(Suppl 2):90-92. doi: 10.1111/nep.12454/full [13] Santos CA, Brennan DC, Fraser VJ, et al. Delayed-onset cytomegalovirus disease coded during hospital readmission after kidney transplantation[J]. Transplantation, 2014, 98(2): 187-194. doi: 10.1097/TP.0000000000000030 [14] Smedbråten YV, Sagedal S, Leivestad T, et al. The impact of early cytomegalovirus infection after kidney transplantation on long-term graft and patient survival[J]. Clin Transplant, 2014, 28(1):120-126. doi: 10.1111/ctr.12288 [15] 宋晓杰, 李丹, 刘伟, 等.肾移植术后肺部感染诊治进展[J].中国老年学杂志, 2014, 34(8): 2312-2314. http://www.cnki.com.cn/Article/CJFDTOTAL-ZLXZ201408147.htmSong XJ, Li D, Liu W, et al. Progress of diagnosis and treatment of pulmonary infection after renal transplantation[J]. Chin J Gerontol, 2014, 34(8):2312-2314. http://www.cnki.com.cn/Article/CJFDTOTAL-ZLXZ201408147.htm [16] Dong B, Wang Y, Wang G, et al. A retrospective study of cytomegalovirus pneumonia in renal transplant patients[J]. Exp Ther Med, 2014, 7(5):1111-1115. https://archive.org/details/pubmed-PMC3991547 [17] Pliquett RU, Asbe-Vollkopf A, Hauser PM, et al. A Pneumocystis jirovecii pneumonia outbreak in a single kidney-transplant center: role of cytomegalovirus co-infection[J]. Eur J Clin Microbiol Infect Dis, 2012, 31(9):2429-2437. doi: 10.1007/s10096-012-1586-x
计量
- 文章访问数: 78
- HTML全文浏览量: 44
- PDF下载量: 12
- 被引次数: 0